Trading Report: Today, TIAA CREF Trust Co. FSB MO Maintains Stake in Cantel Medical Corp. (CMN)

Today, TIAA CREF Trust Co. FSB MO Maintains Stake in Cantel Medical Corp. (CMN)

TIAA CREF Trust Co. FSB MO held its position in shares of Cantel Medical Corp. (NYSE:CMN) during the third quarter, Holdings Channel reports. The fund owned 11,224 shares of the company’s stock at the end of the third quarter. TIAA CREF Trust Co. FSB MO’s holdings in Cantel Medical Corp. were worth $875,000 at the end of the most recent quarter.

Other institutional investors have also made changes to their positions in the company. Great West Life Assurance Co. Can increased its position in shares of Cantel Medical Corp. by 5.0% in the third quarter. Great West Life Assurance Co. Can now owns 48,746 shares of the company’s stock worth $3,799,000 after buying an additional 2,329 shares during the last quarter. State Street Corp increased its position in shares of Cantel Medical Corp. by 1.4% in the first quarter. State Street Corp now owns 698,437 shares of the company’s stock worth $49,838,000 after buying an additional 9,417 shares during the last quarter. Conestoga Capital Advisors LLC increased its position in shares of Cantel Medical Corp. by 2.4% in the third quarter. Conestoga Capital Advisors LLC now owns 622,550 shares of the company’s stock worth $48,546,000 after buying an additional 14,370 shares during the last quarter. Acrospire Investment Management LLC increased its position in shares of Cantel Medical Corp. by 51.2% in the second quarter. Acrospire Investment Management LLC now owns 1,477 shares of the company’s stock worth $102,000 after buying an additional 500 shares during the last quarter. Finally, Kalmar Investments Inc. DE increased its position in shares of Cantel Medical Corp. by 68.4% in the second quarter. Kalmar Investments Inc. DE now owns 285,232 shares of the company’s stock worth $19,604,000 after buying an additional 115,832 shares during the last quarter. Hedge funds and other institutional investors own 83.25% of the company’s stock.

Cantel Medical Corp. (NYSE:CMN) traded up 0.85% during trading on Friday, reaching $81.87. The company had a trading volume of 74,564 shares. The firm has a market capitalization of $3.39 billion, a PE ratio of 56.93 and a beta of 1.41. The firm’s 50 day moving average price is $75.06 and its 200 day moving average price is $72.23. Cantel Medical Corp. has a 12-month low of $55.01 and a 12-month high of $82.80.

Cantel Medical Corp. (NYSE:CMN) last announced its earnings results on Thursday, September 29th. The company reported $0.48 earnings per share for the quarter, beating the Zacks’ consensus estimate of $0.37 by $0.11. Cantel Medical Corp. had a net margin of 9.02% and a return on equity of 16.70%. The business earned $179 million during the quarter. During the same period in the prior year, the business posted $0.39 EPS. Cantel Medical Corp.’s revenue for the quarter was up 18.3% on a year-over-year basis. Equities research analysts forecast that Cantel Medical Corp. will post $1.96 EPS for the current year.

The firm also recently announced a semiannual dividend, which will be paid on Tuesday, January 31st. Shareholders of record on Tuesday, January 17th will be paid a dividend of $0.07 per share. This is an increase from Cantel Medical Corp.’s previous semiannual dividend of $0.06. The ex-dividend date of this dividend is Thursday, January 12th. This represents a dividend yield of 0.18%. Cantel Medical Corp.’s dividend payout ratio (DPR) is currently 8.33%.

CMN has been the topic of a number of research analyst reports. Benchmark Co. began coverage on Cantel Medical Corp. in a research note on Monday, August 29th. They issued a “buy” rating and a $83.00 target price on the stock. Needham & Company LLC began coverage on Cantel Medical Corp. in a research note on Wednesday, August 24th. They issued a “hold” rating on the stock.

In other Cantel Medical Corp. news, Chairman Charles M. Diker sold 14,897 shares of the firm’s stock in a transaction that occurred on Monday, October 10th. The shares were sold at an average price of $78.76, for a total transaction of $1,173,287.72. Following the completion of the transaction, the chairman now owns 3,190,111 shares of the company’s stock, valued at $251,253,142.36. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Also, Chairman Charles M. Diker sold 3,000 shares of the firm’s stock in a transaction that occurred on Thursday, October 20th. The shares were sold at an average price of $75.61, for a total transaction of $226,830.00. Following the transaction, the chairman now directly owns 3,171,270 shares of the company’s stock, valued at approximately $239,779,724.70. The disclosure for this sale can be found here. Company insiders own 15.30% of the company’s stock.

About Cantel Medical Corp.

Cantel Medical Corp. is a provider of infection prevention and control products and services in the healthcare market. The Company’s segments include Endoscopy, Water Purification and Filtration, Healthcare Disposables, Dialysis and Specialty Packaging. Its Endoscopy segment includes medical device reprocessing systems, disinfectants, detergents and other supplies.

Related posts

Leave a Comment